Guided Therapeutics (GTHP) Research & Development (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Research & Development came in at $34000.0 in Q2 2026, down 74.44% year-over-year from $133000.0 in Q2 2025, and down 24.44% quarter-over-quarter from $45000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Research & Development (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Research & Development across 17 years of filings, most recently posting $34000.0 for Q2 2026.
- In Q2 2026, Research & Development fell 74.44% year-over-year to $34000.0; the TTM figure through Jun 2026 stood at $342000.0 (down 25.33% YoY), while the FY2025 annual figure was $469000.0, down 10.84% from the prior year.
- Research & Development came in at $34000.0 for Q2 2026 at Guided Therapeutics, down from $45000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $222000.0 in Q2 2024 to a low of $34000.0 in Q2 2026.
- Average Research & Development over 5 years is $86055.6, with a median of $71000.0 recorded in 2023.
- Year-over-year, Research & Development jumped 236.36% in 2024 and tumbled 74.44% in 2026.
- Over 5 years, Research & Development stood at $52000.0 in 2022, then gained by 25.0% to $65000.0 in 2023, then jumped by 115.38% to $140000.0 in 2024, then slipped by 9.29% to $127000.0 in 2025, then sank by 73.23% to $34000.0 in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $34000.0 in Q2 2026, $45000.0 in Q1 2026, and $127000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | 34,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 41,000.00 |